Johnson & Johnson· @JNJNews · X·· 2026-03-12精选AI 评分50
AI 导读
强生宣布美国FDA已批准一款突破性扩展景深（EDOF）人工晶状体，用于白内障手术。该产品为TECNIS PureSee IOL，配套TECNIS SIMPLICITY递送系统，型号DEN00V，设计目标是在提供清晰视力的同时减少视觉症状。
推荐理由
强生这款EDOF人工晶状体获FDA批准，读者可了解其在白内障手术中减少视觉症状的设计定位。
正文
#NEWS: The U.S. FDA has approved a breakthrough extended depth of focus (EDOF) intraocular lens intended for use in cataract surgery.
This advanced technology is designed to deliver clarity of vision with reduced visual symptoms, helping patients see the world as they expect¹. Learn more: https://social.jnj.com/3NosQf4
For U.S. Audiences Only.
¹TECNIS PureSee™ IOL with TECNIS SIMPLICITY™ Delivery System, Model DEN00V. Directions for Use, current revision.
来源：Johnson & Johnson · x.com